In the latest Health Policy Outlook, John E. Calfee makes the case for substantial social gains from preserving several years of data exclusivity for firms innovating new biotech drugs.
Would you like us to mail you printed copies of publications in addition to your personalized My AEI e-mail updates? Consider enrolling in the AEI Associates Program with a tax-deductible contribution. As an associate, you will receive print versions of many AEI publications, including the AEI Newsletter, On the Issues articles, and The American.